OATV

www.otv.vc

VCMatch tracks OATV as an investor focused on Digital Health, Medtech, and AI/ML companies, Series A and Series B rounds, and Israel, United States, and Europe markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Series A, Series B, Series C, Growth

Focus Areas

Digital Health, Medtech, AI/ML

Geography

Israel, United States, and Europe

Investment Thesis

OTV focuses on partnering with mid-growth digital health startups (Series A or later) that can meaningfully improve global well-being. They combine capital with hands‑on operational support, industry relationships and entrepreneurial experience so portfolio companies can scale from R&D to commercial success while emphasizing founder character and real‑world impact.

Is OATV right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

OATV is most relevant for founders raising Series A, Series B, and Series C rounds in Digital Health, Medtech, AI/ML, and Biotech, especially across Israel, United States, and Europe.

Focus statement

OTV "invests in mid-growth stage, Series A or later, startups in the field of digital health" that "solve a real world problem in healthcare," have "game changing" innovation and a viable business model, with founders who are "passionate, dynamic, and humble, as well as experts in their domain."

Value Add

"We select the most promising digital health ventures to fund, advise and support toward success." — emphasis on funding + advising + supporting, not just capital.
Experienced founding team with proven exits: "Our partners have collectively generated over $4 billion in exit revenue over the last 10 years."
Stage specialization: explicit focus on "mid-growth stage, Series A or later" deals (clarifies target ticketing and value-add stage).
Hands-on, creative support: founders and portfolio cite "creative & hands on approach" and "We provide a lot more than money."
Strong strategic corporate & clinical network: site lists partnerships with "multinational corporations; leading hospitals in the US, Europe and Asia; global medical device companies; and multinational digital companies" for product definition, clinical validation and market access.
Investor transparency & engagement: promises "full transparency, including quarterly reports about our progress and yearly updates at our annual investor summit."
Personable selection process: "Our selection process is personable and supportive, as well as detailed."